These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 5280623)
1. Jaundice after treatment of leukemia with busulphan. Underwood JC; Shahani RT; Blackburn EK Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623 [No Abstract] [Full Text] [Related]
2. Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan. Underwood JC; Shahani RT; Blackburn EK J Clin Pathol; 1970 Dec; 23(9):827. PubMed ID: 5278972 [No Abstract] [Full Text] [Related]
3. Increase in serum alkaline phosphatase (S-ALP) in chronic myelocytic leukemia--sign of drug-induced cholestasis? Hast R Acta Med Scand; 1978; 203(1-2):93-4. PubMed ID: 272822 [TBL] [Abstract][Full Text] [Related]
4. Portal hypertension in a patient with chronic myeloid leukaemia. Foadi MD; Shaw S; Paradinas FJ Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281 [TBL] [Abstract][Full Text] [Related]
5. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia. Key NS; Kelly PM; Emerson PM; Chapman RW; Allan NC; McGee JO Lancet; 1987 Nov; 2(8567):1050-2. PubMed ID: 2889964 [TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan. Vicariot M; Goldman JM; Catovsky D; Galton DA Eur J Cancer (1965); 1979 Apr; 15(4):559-63. PubMed ID: 285861 [No Abstract] [Full Text] [Related]
17. Busulphan and bone marrow depression. Weatherall DJ; Galton DA; Kay HE Br Med J; 1969 Mar; 1(5644):638. PubMed ID: 5250186 [No Abstract] [Full Text] [Related]
18. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan. Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954 [No Abstract] [Full Text] [Related]